The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy
Biotics and Supplements

Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy

JUL 24, 2018
Beiersdorf takes an equity investment into S-Biomedic and collaborates on the skin microbiome
Finance

Beiersdorf takes an equity investment into S-Biomedic and collaborates on the skin microbiome

JUL 20, 2018
Quadrant Biosciences: Researchers Discover Key Link to Understanding Sleep Disorders
Pharma & Human Health

Quadrant Biosciences: Researchers Discover Key Link to Understanding Sleep Disorders

JUL 20, 2018
Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel Disease
Gastrointestinal

Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel Disease

JUL 18, 2018
UAS Labs Announces Licensing Agreement with Acebiome
Pharma & Human Health

UAS Labs Announces Licensing Agreement with Acebiome

JUL 18, 2018
Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics
Finance

Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics

JUL 17, 2018
DuPont Nutrition & Health and Eurofins Bring Higher Level of Transparency to Probiotic Industry Through Genetic Identification
Biotics and Supplements

DuPont Nutrition & Health and Eurofins Bring Higher Level of Transparency to Probiotic Industry Through Genetic Identification

JUL 16, 2018
OxThera Phase 3 Study With Oxabact® in Primary Hyperoxaluria is Now Open for Recruitment
Clinical & Manufacturing

OxThera Phase 3 Study With Oxabact® in Primary Hyperoxaluria is Now Open for Recruitment

JUL 15, 2018
Diversigen and Norgen Biotek Partner to Offer End-to-end Solutions for Microbiome Sample and Analysis Research
Pharma & Human Health

Diversigen and Norgen Biotek Partner to Offer End-to-end Solutions for Microbiome Sample and Analysis Research

JUL 15, 2018
Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield(TM)
Pharma & Human Health

Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield(TM)

JUL 6, 2018
Jennewein Biotechnologie to Build New R&D Centre for Synthetic Organisms and Microbiome Research in Bonn, Germany
Pharma & Human Health

Jennewein Biotechnologie to Build New R&D Centre for Synthetic Organisms and Microbiome Research in Bonn, Germany

JUL 5, 2018